Trident Lifeline Ltd announced a strategic alliance with National Institutes of Pharmaceutical Education and Research (NIPER-Ahmedabad) on March 5, 2025, to transfer technology for the cancer treatment drug Vorinostat, making it accessible to Indian patients, particularly those from economically disadvantaged backgrounds.